LZU-24760-36401
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 960 / CA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-26
- 2020-12-28
- 2020-12-29
- 2021-01-07
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-20
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · None · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 35, dose 2MedDRA: Respiratory symptom, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Mild URI symptoms. Sneezing and runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Herpes zoster, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Shingles · Healthcare visit (other): Primary careMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-13
Survey response — 6 months, dose 2MedDRA: Herpes zoster — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: ShinglesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-23
-
2021-07-23
Call successfulParticipant prefers to complete VAERS report online
- 2022-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 4 — day 35, dose 2
Symptoms: Mild URI symptoms. Sneezing and runny nose
Release 7 — 3 months, dose 2
Release 9 — 6 months, dose 2
Symptoms: Shingles
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
| SD | Respiratory symptom | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release